Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/21/1995 | WO1995034202A1 Methods for reducing hyperacute rejection of xenografts |
12/21/1995 | WO1995034201A1 pp60PIK: A DOWNSTREAM ELEMENT IN INSULIN SIGNALING |
12/21/1995 | WO1995033048A3 P2x receptors (purinoceptor family) |
12/21/1995 | WO1995032731A3 Immunogenic pharmaceuticals |
12/21/1995 | WO1995030748A3 Plant u14 nucleic acid sequences and derivatives thereof |
12/21/1995 | WO1995027790A3 Dna sequences coding for a cynnamoyl coa reductase and their use in the regulation of plant lignin concentrations |
12/21/1995 | WO1995027066A3 Dna encoding ubiquitin conjugating enzymes |
12/21/1995 | CA2576396A1 Adeno-associated virus materials and methods |
12/21/1995 | CA2193072A1 Corticotropin-releasing factor2 receptors |
12/21/1995 | CA2192982A1 Ungulate eg cell |
12/21/1995 | CA2192844A1 Fas associated proteins |
12/21/1995 | CA2192660A1 Methods for reducing hyperacute rejection of xenografts |
12/21/1995 | CA2192655A1 Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
12/21/1995 | CA2192552A1 Transformation of guar |
12/21/1995 | CA2192486A1 Pp60pik: a downstream element in insulin signaling |
12/21/1995 | CA2192334A1 Isolated nucleic acid encoding retinol dehydrogenase |
12/21/1995 | CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
12/21/1995 | CA2191845A1 Retroviral gene therapy vectors and therapeutic methods based thereon |
12/21/1995 | CA2191441A1 Use of anthocyanin genes to maintain male sterile plants |
12/21/1995 | CA2191065A1 Compositions and methods for the treatment of tumors |
12/20/1995 | EP0687301A1 Prohormone convertase transformed cells and polypeptide synthesis |
12/20/1995 | EP0687296A1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
12/20/1995 | EP0687295A1 Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
12/20/1995 | EP0687294A1 Human liver epithelial cell lines |
12/20/1995 | EP0687185A1 Process for producing an implant from cell cultures |
12/20/1995 | EP0687180A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
12/20/1995 | EP0673382A4 METHODS AND COMPOSITIONS FOR cDNA SYNTHESIS. |
12/20/1995 | EP0633719A4 INDUCTION OF SOMATIC EMBRYOGENESIS IN -i(TAXUS), AND THE PRODUCTION OF TAXANE-RING CONTAINING ALKALOIDS THEREFROM. |
12/20/1995 | EP0629237B1 Device for cell culture treatment |
12/20/1995 | EP0528898B1 Growing ehrlichia species in a continuous cell line |
12/20/1995 | EP0502036B1 Latency associated peptide and uses therefor |
12/20/1995 | EP0462269B1 Cell encapsulating method and apparatus |
12/20/1995 | EP0394424B1 Peptides and polypeptides from the sub-maxilary gland of the rat, corresponding monoclonal and polyclonal antibodies, corresponding hybridomas and applications of said products to the diagnosis, detection or for therapeutical purposes |
12/20/1995 | CN1113518A A novel peptide related to human programmed cell death and DNA encoding it |
12/19/1995 | US5477001 Recombinant DNA coding for a novel protein having β-1,3-glucanase activity, bacteria containing this DNA, transformed plant cells and plants |
12/19/1995 | US5476782 DNA encoding a human 5-HT1E receptor and uses thereof |
12/19/1995 | US5476781 Genetic engineering |
12/19/1995 | US5476780 Culturing together with interstitial cells of mammalian thymus in a nutrient medium having selective dissolved oxygen concentration |
12/19/1995 | US5476778 Method of growing and attenuating a viral agent associated with mystery swine disease |
12/19/1995 | US5476777 Methods for producing thrombin |
12/19/1995 | US5476523 Moss seedling and method of producing dense moss mat therefrom |
12/19/1995 | CA2056988C Production of improved rapeseed exhibiting a reduced saturated fatty acid content |
12/19/1995 | CA1337755C Monoclonal antibodies for human non-small cell lung carcinomas |
12/18/1995 | CA2151627A1 Recombinant gibberellin dna and uses thereof |
12/15/1995 | CA2150994A1 P53as protein and antibody therefor |
12/14/1995 | WO1995033855A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
12/14/1995 | WO1995033840A1 Recombinant viruses, preparation and use thereof in gene therapy |
12/14/1995 | WO1995033829A1 Pantropic neurotrophic factors |
12/14/1995 | WO1995033823A1 Methods for selectively stimulating proliferation of t cells |
12/14/1995 | WO1995033822A1 Growth medium for conifer embryogenic tissue |
12/14/1995 | WO1995033821A1 Three-dimensional cartilage cultures |
12/14/1995 | WO1995033818A2 Genes for the synthesis of antipathogenic substances |
12/14/1995 | WO1995033771A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
12/14/1995 | WO1995033770A1 Ligands for induction of antigen specific apoptosis in t cells |
12/14/1995 | WO1995033553A1 Polymeric microbeads and method of preparation |
12/14/1995 | WO1995031564A3 Method of introducing pathogen resistance in plants |
12/14/1995 | DE4412794A1 Verfahren zur Herstellung von dendritischen Zellen, so erhaltene Zellen und Behälter zur Durchführung dieses Verfahrens A process for the preparation of dendritic cells thus obtained cells and container for carrying out this method |
12/14/1995 | CA2704083A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
12/14/1995 | CA2192370A1 Monoclonal antibody active against cd44v6 |
12/14/1995 | CA2192366A1 Genes for the synthesis of antipathogenic substances |
12/14/1995 | CA2192064A1 Three-dimensional cartilage cultures |
12/14/1995 | CA2191728A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
12/14/1995 | CA2191610A1 Ligands for induction of antigen specific apoptosis in t cells |
12/14/1995 | CA2191586A1 Methods for selectively stimulating proliferation of t cells |
12/14/1995 | CA2190731A1 Polymeric microbeads and method of preparation |
12/13/1995 | EP0686695A1 Rat protein kinare C and production thereof |
12/13/1995 | EP0686397A2 Use of chondroitin sulphate proteoglycans for protection of neurons |
12/13/1995 | EP0686202A1 Prenatal screening |
12/13/1995 | EP0686197A1 Geminivirus-based gene expression system |
12/13/1995 | EP0686196A1 Plant virus resistance conferring polyribozyme and resistant plants producing same |
12/13/1995 | EP0686192A1 Method of enhanging fertility |
12/13/1995 | EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT |
12/13/1995 | EP0403574B1 Microtuber propagation of potatoes |
12/13/1995 | CN1113390A Defective adenovirus vectors and use thereof in gene therapy |
12/12/1995 | US5475100 An antibody having antigen binding activity and which has a heavy chain constant region into which has been inserted arganine-glycine-aspartic acid and serine amino acid sequence, giving antibody affinity for cells |
12/12/1995 | US5475099 Plant fatty acid synthases |
12/12/1995 | US5475087 Polypeptides |
12/12/1995 | US5474931 Media concentrate technology |
12/12/1995 | US5474930 Non-tumorigenic cell lines for expression of genes |
12/12/1995 | US5474771 Inhibits T cell activation of B cells ; binds to epitope |
12/12/1995 | US5474770 Biological support for cell cultures constituted by plasma proteins coagulated by thrombin, its use in the preparation of keratocyte cultures, their recovery and their transport for therapeutic purposes |
12/12/1995 | US5474755 Contacting human tissue with a human monoclonal antibody or antigen binding fragment; detection; identification of tumor cells |
12/12/1995 | US5474687 Layering cell mixture into centrifuge tube having annular member with opening and containing density gradient solution, centrifuging to pelletize cells having higher densities, collecting cells enriched in desired cells from upper portion |
12/12/1995 | US5474547 Parkinson disease, epilepsy |
12/12/1995 | CA1337717C Monoclonal antibodies against human necrosis factor (tnf) _ use thereof for detecting tnf in samples, and pharmaceutical compositions containing them |
12/11/1995 | CA2151446A1 Modified satellite rnas and satellite viruses as carriers of adapted ribozymes |
12/07/1995 | WO1995033297A1 Electromagnetically controlled gear engagement mechanism integrated with a magnetic hysteresis slip clutch |
12/07/1995 | WO1995033062A2 Method for introducing foreign matter into higher eukaryotic cells |
12/07/1995 | WO1995033061A1 Method for introducing nucleic acid in higher eukaryotic cells |
12/07/1995 | WO1995033059A2 Receptor for oncostatin m |
12/07/1995 | WO1995033057A1 Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation |
12/07/1995 | WO1995033055A2 Wax esters in transformed plants |
12/07/1995 | WO1995033053A1 Hepatitis c virus asialoglycoproteins |
12/07/1995 | WO1995033051A1 Tumor necrosis factor receptor-associated factors |
12/07/1995 | WO1995033048A2 P2x receptors (purinoceptor family) |
12/07/1995 | WO1995032988A1 Novel parasite protease genes and proteins |
12/07/1995 | WO1995032743A1 Temporary biologically active cover for extensive wound areas and method of preparing thereof |
12/07/1995 | WO1995032740A1 Transformed human hepatoma cell line which releases insulin |
12/07/1995 | WO1995032734A1 New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness |
12/07/1995 | WO1995032731A2 Immunogenic pharmaceuticals |